Immune Design Corp.
IMDZ
IMDZ was delisted on the 1st of April, 2019.
41 hedge funds and large institutions have $294M invested in Immune Design Corp. in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 3 closing their positions.
433% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 3
363% more capital invested
Capital invested by funds: $63.5M → $294M (+$230M)
75% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 8
46% more funds holding
Funds holding: 28 → 41 (+13)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
+$8.31M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$1.52M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.33M |
| 4 |
HLA
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
+$1.19M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$1.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.48M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.26M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$2.05M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$1.78M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.67M |
IMDZ Hedge Fund Activity: Q4 2014 in Review
41 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q4 2014, worth a combined $294M — up 363% from $63.5M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new IMDZ positions and 3 closed out — a net gain of 13 holders — while 14 added to existing stakes and 8 trimmed.
The largest buyer was RS Investment Management, opening a new position worth an estimated $8.31M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $2.48M sold.
- 41 institutional investors held Immune Design Corp. (IMDZ) as of Q4 2014, up from 28 in Q3 2014.
- Funds reported $294M of Immune Design Corp. stock for Q4 2014, up 363% quarter-over-quarter.
- 16 funds opened new Immune Design Corp. positions in Q4 2014 and 3 closed out, a net change of +13 holders.
- The largest Immune Design Corp. buyer in Q4 2014 was RS Investment Management, an estimated $8.31M added.
- The largest Immune Design Corp. seller in Q4 2014 was Driehaus Capital Management, an estimated $2.48M sold.
Based on aggregated 13F filings for Q4 2014.